TLRY($552M) has a higher market cap than IMCC($1.06M). TLRY YTD gains are higher at: -55.482 vs. IMCC (-95.803). TLRY has higher annual earnings (EBITDA): 9.45M vs. IMCC (-11.89M). TLRY has more cash in the bank: 231M vs. IMCC (1.62M). IMCC has less debt than TLRY: IMCC (13.8M) vs TLRY (398M). TLRY has higher revenues than IMCC: TLRY (915M) vs IMCC (45.8M).

	IMCC	TLRY	IMCC / TLRY
Capitalization	1.06M	552M	0%
EBITDA	-11.89M	9.45M	-126%
Gain YTD	-95.803	-55.482	173%
P/E Ratio	N/A	N/A	-
Revenue	45.8M	915M	5%
Total Cash	1.62M	231M	1%
Total Debt	13.8M	398M	3%

FUNDAMENTALS RATINGS

IMCC vs TLRY: Fundamental Ratings

	IMCC	TLRY
OUTLOOK RATING 1..100	76	55
VALUATION overvalued / fair valued / undervalued 1..100	24 Undervalued	35 Fair valued
PROFIT vs RISK RATING 1..100	100	100
SMR RATING 1..100	100	93
PRICE GROWTH RATING 1..100	97	84
P/E GROWTH RATING 1..100	100	91
SEASONALITY SCORE 1..100	50	50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMCC's Valuation (24) in the null industry is in the same range as TLRY (35) in the Biotechnology industry. This means that IMCC’s stock grew similarly to TLRY’s over the last 12 months.

IMCC's Profit vs Risk Rating (100) in the null industry is in the same range as TLRY (100) in the Biotechnology industry. This means that IMCC’s stock grew similarly to TLRY’s over the last 12 months.

TLRY's SMR Rating (93) in the Biotechnology industry is in the same range as IMCC (100) in the null industry. This means that TLRY’s stock grew similarly to IMCC’s over the last 12 months.

TLRY's Price Growth Rating (84) in the Biotechnology industry is in the same range as IMCC (97) in the null industry. This means that TLRY’s stock grew similarly to IMCC’s over the last 12 months.

TLRY's P/E Growth Rating (91) in the Biotechnology industry is in the same range as IMCC (100) in the null industry. This means that TLRY’s stock grew similarly to IMCC’s over the last 12 months.

TECHNICAL ANALYSIS

Technical Analysis

	IMCC	TLRY
RSI ODDS (%)	2 days ago 88%	2 days ago 89%
Stochastic ODDS (%)	2 days ago 87%	2 days ago 75%
Momentum ODDS (%)	2 days ago 90%	2 days ago 90%
MACD ODDS (%)	2 days ago 90%	2 days ago 90%
TrendWeek ODDS (%)	2 days ago 90%	2 days ago 89%
TrendMonth ODDS (%)	2 days ago 90%	2 days ago 88%
Advances ODDS (%)	24 days ago 84%	10 days ago 80%
Declines ODDS (%)	5 days ago 90%	2 days ago 90%
BollingerBands ODDS (%)	2 days ago 90%	2 days ago 83%
Aroon ODDS (%)	2 days ago 90%	2 days ago 73%

COMPARISON

Comparison

Sep 12, 2026

Stock price -- (IMCC: $1.75 vs. TLRY: $4.02)

Brand notoriety: IMCC: Not notable vs. TLRY: Notable

Both companies represent the Pharmaceuticals: Generic industry

Current volume relative to the 65-day Moving Average: IMCC: 60% vs. TLRY: 104%

Market capitalization -- IMCC: $1.06M vs. TLRY: $552.39M

IMCC [@Pharmaceuticals: Generic] is valued at $1.06M. TLRY’s [@Pharmaceuticals: Generic] market capitalization is $552.39M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $63.66B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMCC’s FA Score shows that 1 FA rating(s) are green while TLRY’s FA Score has 0 green FA rating(s).

IMCC’s FA Score: 1 green, 4 red.
TLRY’s FA Score: 0 green, 5 red.

According to our system of comparison, both IMCC and TLRY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMCC’s TA Score shows that 2 TA indicator(s) are bullish while TLRY’s TA Score has 5 bullish TA indicator(s).

IMCC’s TA Score: 2 bullish, 8 bearish.
TLRY’s TA Score: 5 bullish, 5 bearish.

According to our system of comparison, TLRY is a better buy in the short-term than IMCC.

Price Growth

IMCC (@Pharmaceuticals: Generic) experienced а -11.62% price change this week, while TLRY (@Pharmaceuticals: Generic) price change was -10.67% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -5.31%. For the same industry, the average monthly price growth was -4.84%, and the average quarterly price growth was +30.17%.

Industries' Descriptions

@Pharmaceuticals: Generic (-5.31% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three

IMCC

Daily Signal:

Gain/Loss:

TLRY

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

Interesting Tickers

MFs / NAME	Price $	Chg $	Chg %
		1 Day
CPOCX	18.48	N/A	N/A
Morgan Stanley Insight L
IEOSX	15.97	N/A	N/A
Voya Large Cap Growth Port S
JABNX	49.59	N/A	N/A
Janus Henderson Balanced N
TGRGX	7.04	N/A	N/A
Transamerica International Focus I
QCGAX	16.29	N/A	N/A
Quantified Common Ground Advisor

IMCC and

Correlation & Price change

A.I.dvisor tells us that IMCC and TXMD have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMCC and TXMD's prices will move in lockstep.

Ticker / NAME	Correlation To IMCC	1D Price Change %
IMCC	100%	N/A
TXMD - IMCC	25% Poorly correlated	+2.86%
TLRY - IMCC	24% Poorly correlated	-2.90%
ACB - IMCC	24% Poorly correlated	+0.27%
SCYX - IMCC	22% Poorly correlated	+2.98%
SNDL - IMCC	22% Poorly correlated	N/A
More

TLRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, TLRY has been closely correlated with SNDL. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if TLRY jumps, then SNDL could also see price increases.

Ticker / NAME	Correlation To TLRY	1D Price Change %
TLRY	100%	-2.90%
SNDL - TLRY	76% Closely correlated	N/A
CGC - TLRY	74% Closely correlated	-0.25%
ACB - TLRY	73% Closely correlated	+0.27%
CRON - TLRY	64% Loosely correlated	-0.63%
OGI - TLRY	57% Loosely correlated	-1.87%
More